Doyle John Brendan 4

What Happened
John Brendan Doyle, Chief Financial Officer of Cognition Therapeutics (CGTX), had 1,560 shares withheld by the company to satisfy tax-withholding obligations tied to the vesting of restricted stock units (RSUs). The withholding was reported at $1.12 per share, totaling approximately $1,747. This is a routine tax-withholding disposition, not an open-market sale or a purchase.

Key Details

• Transaction date: 2026-02-15; Filing date: 2026-02-18 (appears timely).
• Action: Shares withheld to cover taxes (transaction code F).
• Quantity withheld/disposed: 1,560 shares at $1.12 per share (total ~$1,747).
• Footnote: F1 — shares were withheld by the issuer to cover tax withholding on RSU vesting.
• Shares owned after transaction: not specified in the provided filing excerpt.

Context
Withholding shares to cover taxes on vested RSUs is a common administrative action and generally does not signal a deliberate sale by the insider. It reduces the insider’s share count but is done to meet tax obligations rather than to raise cash or express a view on the company's stock.